The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.

S. Moreira (Lisboa, Portugal)

Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Session: Classifying COPD with multidimensional scores and biomarkers
Session type: Thematic Poster
Number: 1113
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Moreira (Lisboa, Portugal). The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.. 1113

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013

Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013


Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Usefulness of COPD assessment test (CATÔ) for the management of COPD according to GOLD 2011
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012


GOLD 2011 versus GOLD 2017 – What does change?
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


The number of asthma attacks reported by subjects with physician-diagnosed asthma in Italy has increased from 1998-2000 to 2007-2010. Preliminary results
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012

The correlation of new GOLD classification (2011 version) with exercise capacity and mortality
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Hospitalisations for exacerbations of COPD, France, 1998-2007
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009


Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

COPD prevalence in Spain in 2007 (EPI-SCAN study results)
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015


Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



The incidence, prevalence and features of the course of pulmonary sarcoidosis (PS) in Saint-Petersburg for 1998-2006 years
Source: Annual Congress 2007 - Epidemiology of various lung diseases
Year: 2007